Immunolocalization and messenger RNA expression of bone morphogenetic protein-6 in human benign and malignant prostatic tissue

Cancer Research

Volumn 57, Issue 19, 1997, Pages 4427-4431

  Hamdy, Freddie C ^a,b   Autzen, Pernille ^a   Robinson, Mary C ^b   Horne, C H Wilson ^a   Neal, David E ^a   Robson, Craig N ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b FREEMAN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; MESSENGER RNA; PLASMINOGEN ACTIVATOR;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BONE METASTASIS; CLINICAL ARTICLE; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; OSTEOBLAST; OTOSCLEROSIS; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION;

ADENOCARCINOMA; BLOTTING, WESTERN; BONE MORPHOGENETIC PROTEINS; BONE NEOPLASMS; CYTOPLASM; EPITHELIUM; HUMANS; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION; MALE; NEOPLASM PROTEINS; PROSTATE; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 0030845818     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Urist, M. R. Bone formation by autoinduction. Science (Washington DC), 150: 893-899, 1965.
2. Dube, J. L., and Celeste, A. J. Human bone morphogenetic protein-15, a new member of the transforming growth factor β superfamily. J. Bone Miner. Res., 11 (Suppl. 1): T330, 1996.
3. Lyons, K. M., Pelton, R. W., and Hogan, B. L. M. Patterns of expression of murine Vgr-1 and BMP2a RNA suggest that transforming growth factor-β-like genes coordinately regulate aspects of embryonic development. Genes Dev., 3: 1657-1668, 1989.
4. Lyons, K. M., Jones, C. M., and Hogan, B. L. M. The DVR gene family in embryonic development. Trends Genet., 7: 408-412, 1991.
5. Møller Jensen, O., Estève, J., Møller, H., and Renard, H. Cancer in the European community and its member states. Eur. J. Cancer, 26: 1167-1256, 1990.
6. Parker, S. L., Tong, T., Bolden, S., and Wingo, P. A. Cancer statistics. CA Cancer J. Clin., 65: 5-27, 1996.
7. Ware, J. L. Growth factors and their receptors as determinants in the proliferation and metastasis of human prostate cancer. Cancer Metastasis Rev., 12: 287-301, 1993.
8. Rabbani, S. A., Desjardins, J., Bell, A. W., Banville, D., Henkin, J., and Goltzman, D. An amino-terminal fragment of urokinase isolated from a prostate cancer cell line (PC-3) is mitogenic for osteoblast-like cells. Biochem. Biophys. Res. Commun., 173: 1058-1064, 1990.
9. Bentley, H., Hamdy, F. C., Hart, K. A., Seid, J. M., Williams, J. L., Johnstone, D., and Russell, R. G. G. Expression of bone morphogenic proteins in human prostatic adenocarcinoma and benign prostatic hyperplasia. Br. J. Cancer, 66: 1159-1163, 1992.
10. Harris, S. E., Harris, M. A., Mahy, P., Wozney, J., Feng, J. Q., and Mundy, G. R. Expression of bone morphogenetic protein messenger RNAs by normal rat and human prostate and prostate cancer cells. Prostate, 24: 204-211, 1994.
11. Barnes, J., Anthony, C. T., Wall, N., and Steiner, M. S. Bone morphogenetic protein-6 expression in normal and malignant prostate. World J. Urol., 13: 337-343, 1995.
12. Chen, D., Feng, J. Q., Feng, M., Harris, M. A., Mahy, P., Mundy, G. R., and Harris, S. E. Sequence and expression of bone morphogenetic protein-3 messenger-RNA in prolonged cultures of fetal-rat calvarial osteoblasts and in rat prostate adenocarcinoma PA-III cell. DNA Cell Biol., 14: 235-239, 1995.
13. Celeste, A. J., Iannazzi, J. A., Taylor, R. C., Hewick, R. M., Rosen, V., Wang, E. A., and Wozney, J. M. Identification of transforming growth factor β family members present in bone-inductive protein purified from bovine bone. Proc. Natl. Acad. Sci. USA, 87: 9843-9847, 1990.
14. Fischer, C., Angus, B., and Rees, J. In situ hybridisation using digoxigenin labelled probes in human skin. Br. J. Dermatol., 125: 516-520, 1991.
15. Adams, J. C. Biotin amplication of biotin and horseradish peroxidase signals in histochemical stains. J. Histochem. Cytochem., 40: 1457-1463, 1992.
16. Kaighn, M. E. Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest. Urol., 17: 16-23, 1979.
17. Stone, K. R. Isolation of a human prostate carcinoma cell line (DU 145). Int. J. Cancer, 21: 274-281, 1978.
18. Özkaynak, E., Rueger, D. C., Drier, E. A., Corbett, C., Ridge, R. J., Sampath, T. K., and Oppermann, H. OP-1 cDNA encodes and osteogenic protein in the TGF-β family. EMBO J., 9: 2085-2093, 1990.
19. Bonkhoff, H., Stein, U., and Remberger, K. The proliferative function of basal cells in the normal and hyperplastic human prostate. Prostate, 24: 114-118, 1994.
20. Bonkhoff, H., and Remberger, K. Differentiation pathway and histogenic aspects of normal and abnormal prostatic growth: a stem cell model. Prostate, 28: 98-106, 1996.
21. Hughes, F. J., Collyer, J., Stanfield, M., and Goodman, S. A. The effects of bone morphogenetic protein-2, protein-4, and protein-6 on differentiation of rat osteoblast cells in vitro. Endocrinology, 136: 2671-2677, 1995.
22. Schröder, F. H., Hermanek, P., Denis, L., Fair, W., Gospodarowicz, M. K., and Pavone-Macaluso, M. The TNM classification of prostate cancer. Prostate, 4 (Suppl.): 129-138, 1992.